...
【24h】

Cerebrospinal fluid markers for prediction of Alzheimer's disease.

机译:脑脊液标记物可预测阿尔茨海默氏病。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A major diagnostic challenge when people seek advice for cognitive dysfunction is to differentiate between mild cognitive impairment (MCI) and incipient Alzheimer's disease (AD). We show that a combination of three cerebrospinal fluid biochemical markers, total-tau, phospho-tau and beta-amyloid(1-42), can detect incipient AD among patients fulfilling the criteria for MCI with a sensitivity of 68% (95% CI 45-86%) and a specificity of 97% (95% CI 83-100%). The usefulness of these markers is further emphasized by the finding of a positive predictive value of 94% and a negative predictive value of 81%.
机译:人们寻求认知功能障碍的建议时,主要的诊断挑战是区分轻度认知障碍(MCI)和初期阿尔茨海默氏病(AD)。我们显示,三种脑脊液生化标记物,总-tau,磷酸-tau和β-淀粉样蛋白(1-42)的组合可以在满足MCI标准的患者中检测初期AD,敏感性为68%(95%CI 45-86%)和97%的特异性(95%CI 83-100%)。通过发现94%的阳性预测值和81%的阴性预测值,进一步强调了这些标记的实用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号